BenefitsLink logo
EmployeeBenefitsJobs logo
Featured Jobs
Senior Retirement Plan Administrator (Philadelphia PA / Telecommute)

Plan Administrator (Lake Mary FL / Richmond VA / Dallas TX / Los Angeles CA)
Free Daily News and Jobs

“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
Get the BenefitsLink app LinkedIn
Twitter
Facebook

News Items, by Subject

Health plan costs - prescription drugs


Now Viewing
Headlines
View Excerpts and
Headlines

[Opinion] There Is No Single, Best Policy for Drug Prices
How Blockchain Technology Will Disrupt the PBM-Payer-Pharmacy Relationship
Administration Drops Plan to Curb Drug Rebates
Will Prescription Drug Price Disclosures Have an Impact?
How to Get a Cheaper Prescription Before Leaving the Doctor's Office
Drug Price Disclosures and the First Amendment
District Court Vacates HHS Rule That Would Require Drug Price Disclosure in TV Ads
Supreme Court Seeks Solicitor General's Input on ERISA Preemption of State Regulation of Pharmacy Benefit Managers
[Opinion] Maryland's Path to a Prescription Drug Affordability Board
Rebalancing High Prescription Drug Prices with Innovation Incentives
Pelosi Aims for Feds to Negotiate Drug Prices, Even for Private Insurers
New Texas Law Mandating Drug Price Transparency Considered Among Strongest in Nation
[Opinion] A Simple Solution to Lower Drug Prices for All Americans
[Guidance Overview] Oklahoma Enacts Regulation of Pharmacy Benefit Managers
Senate Committee Hearing: The Complex Web of Prescription Drug Prices -- Examining Agency Efforts to Further Competition and Increase Affordability
Senate Package Targets Healthcare Costs, Surprise Medical Bills
[Opinion] Transparency, Regulation Needed to Rein in Pharmacy Benefit
How External Reference Pricing Could Address Price Disparities Between Drugs in the U.S. and Other Nations
Witnesses Testify in Review of CVS-Aetna Merger
[Opinion] Transparency Is Just One Piece of the Drug Pricing Puzzle
Arbitration Approach Favored in Pending Surprise-Bill Legislation
Policy Options to Help Self-Insured Employers Improve PBM Contracting Efficiency
Oklahoma Governor Signs Law Regulating PBMs
Bipartisan Support for New Attempts to Control Prescription Drug Costs
How Does Prescription Drug Spending and Use Compare Across Large Employer Plans, Medicare Part D, and Medicaid?
Opioid Prescriptions Drop Sharply Among California State Workers
CBO Reply to Sen. Grassley: Negotiation Over Drug Prices in Medicare
House Passes Legislation to Strengthen the ACA
[Guidance Overview] CMS Takes Action to Lower Prescription Drug Prices and Increase Transparency
[Official Guidance] Text of CMS Final Regs: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses
A Plan to Lower Prescription Drug Prices
Drug Price Disclosures and the First Amendment
Lawsuit Against Generic Drug Manufacturers Alleges Conspiracy to Fix Prices for Over 100 Drugs
Policy Proposals to Increase Patient Access and Improve Affordability for Prescription Drugs (PDF)
[Opinion] A Doctor Tells Pharmacy Benefit Managers: Stop 'Treating' My Cancer Patients
Health Plans Should Prepare for Fallout from HHS Rule Requiring Manufacturers to Disclose Drug Prices
House Subcommittee Hearing: Lowering Prescription Drug Prices -- Deconstructing the Drug Supply Chain
[Opinion] Why the New HHS Drug Rebate Rule Deserves (Cautious) Support
[Official Guidance] Text of CMS Final Regs Requiring Drug Pricing Transparency for Medicare and Medicaid Programs
House Committee Approves Drug Price Transparency Legislation/Drug Sample Reporting Requirement Under Sunshine Act
The Money and Politics of Prescription Drugs: What You Need to Know
District Court Tells HHS to Revisit 340B Drug Discounts After Ruling Cuts 'Unlawful'
Three Major PBMs Show Lower Drug Trend Across Commercial Clients
Out-of-Pocket Costs Go Through the Roof for Neurology Drugs
CBO Updated Budget Projections Incorporating the Effects of the Proposed Rule on Safe Harbors for Pharmaceutical Rebates (PDF)
The Obscure Advisory Committees at the Heart of the U.S. Drug Pricing Debate
Ohio Attorney General Calls for Legislation to Address State's Arrangements with PBMs
Are States Trending Toward Prescription Drug Affordability Boards?
Women, Uninsured More Likely to Use Strategies to Reduce Prescription Drug Costs
33% of U.S. Workforce Using Prescription Pain Medications
Eliminating Drug Rebates: How Might Access and Pricing be Affected?
[Opinion] Reining In Drug Costs: No Easy Fix
Senate Hearing on Drug Pricing Provides a Lesson in What PBMs Do
Maryland at the Forefront of Groundbreaking Legislation to Lower Drug Prices
[Opinion] American Benefits Council Comment Letter to HHS on Proposed Regs for Prescription Drug Rebates and Safe Harbors
Senate Bill Would End Drug Rebates in Employer Plans
Administration's 2020 Budget Proposal Addresses Retirement, Health Care and Paid Leave
[Opinion] American Academy of Actuaries Letter to CMS on Changes to Safe Harbors for Rebates Involving Prescription Pharmaceuticals (PDF)
Cigna, Express Scripts Capping Insulin Co-Pays to $25 for Participating Commercial Members
Drug Rebates May Soon Be a Thing of the Past
 
About Us

Testimonials

Privacy Policy

Post a Job

Advertise in the BenefitsLink Newsletters

Add Your Company to the Directory of Vendors and Software

Submit a News Item, Press Release, Webcast or Conference

Contact Us

Payment Portal

© 2019 BenefitsLink.com, Inc.